FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034458704> ?p ?o ?g. }

• W2034458704 endingPage "263" @default.
• W2034458704 startingPage "263" @default.
• W2034458704 abstract "Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia Alpo Vuorio,1,2 Matti J Tikkanen,3 Petri T Kovanen4 1Health Center Mehiläinen, Vantaa, Finland; 2Finnish Institute of Occupational Health, Lappeenranta, Finland; 3Heart and Lung Center, Helsinki University Central Hospital, Folkhälsan Research Center, Biomedicum, Helsinki, Finland; 4Wihuri Research Institute, Biomedicum, Helsinki, Finland Abstract: Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the low-density lipoprotein (LDL)-receptor gene (LDLR). Patients with homozygous FH (hoFH) have inherited a mutated LDLR gene from both parents, and therefore all their LDL-receptors are incapable of functioning normally. In hoFH, serum LDL levels often exceed 13 mmol/L and tendon and cutaneous xanthomata appear early (under 10 years of age). If untreated, this extremely severe form of hypercholesterolemia may cause death in childhood or in early adulthood. Based on recent data, it can be estimated that the prevalence of hoFH is about 1:500,000 or even 1:400,000. Until now, the treatment of hoFH has been based on high-dose statin treatment combined with LDL apheresis. Since the LDL cholesterol-lowering effect of statins is weak in this disease, and apheresis is a cumbersome treatment and not available at all centers, alternative novel pharmaceutical therapies are needed. Lomitapide is a newly introduced drug, capable of effectively decreasing serum LDL cholesterol concentration in hoFH. It inhibits the microsomal triglyceride transfer protein (MTTP). By inhibiting in hepatocytes the transfer of triglycerides into very low density lipoprotein particles, the drug blocks their assembly and secretion into the circulating blood. Since the very low density lipoprotein particles are precursors of LDL particles in the circulation, the reduced secretion of the former results in lower plasma concentration of the latter. The greatest concern in lomitapide treatment has been the increase in liver fat, which can be, however, counteracted by strictly adhering to a low-fat diet. Lomitapide is a welcome addition to the meager selection of drugs currently available for the treatment of refractory hypercholesterolemia in hoFH patients. Keywords: microsomal triglyceride transfer protein inhibitor, familial hypercholesterolemia, LDL-cholesterol, metabolism, lomitapide" @default.
• W2034458704 created "2016-06-24" @default.
• W2034458704 creator A5019289431 @default.
• W2034458704 creator A5085702429 @default.
• W2034458704 creator A5085875890 @default.
• W2034458704 date "2014-05-01" @default.
• W2034458704 modified "2023-10-17" @default.
• W2034458704 title "Inhibition of hepatic microsomal triglyceride transfer protein &ndash; a novel therapeutic option for treatment of homozygous familial hypercholesterolemia" @default.
• W2034458704 cites W1543117447 @default.
• W2034458704 cites W1569405015 @default.
• W2034458704 cites W1662506416 @default.
• W2034458704 cites W1685331907 @default.
• W2034458704 cites W1817964822 @default.
• W2034458704 cites W1968949098 @default.
• W2034458704 cites W1970935527 @default.
• W2034458704 cites W1974471798 @default.
• W2034458704 cites W1977016172 @default.
• W2034458704 cites W1977761476 @default.
• W2034458704 cites W1978080134 @default.
• W2034458704 cites W1982975022 @default.
• W2034458704 cites W1987231023 @default.
• W2034458704 cites W1991671549 @default.
• W2034458704 cites W1992969017 @default.
• W2034458704 cites W1994621034 @default.
• W2034458704 cites W1996927396 @default.
• W2034458704 cites W2004357142 @default.
• W2034458704 cites W2004410658 @default.
• W2034458704 cites W2004854768 @default.
• W2034458704 cites W2005935428 @default.
• W2034458704 cites W2007654682 @default.
• W2034458704 cites W2009257021 @default.
• W2034458704 cites W2014628902 @default.
• W2034458704 cites W2018686032 @default.
• W2034458704 cites W2019676124 @default.
• W2034458704 cites W2024864273 @default.
• W2034458704 cites W2026205222 @default.
• W2034458704 cites W2028976140 @default.
• W2034458704 cites W2031733687 @default.
• W2034458704 cites W2034067112 @default.
• W2034458704 cites W2036394293 @default.
• W2034458704 cites W2038366195 @default.
• W2034458704 cites W2040612932 @default.
• W2034458704 cites W2042381594 @default.
• W2034458704 cites W20433271 @default.
• W2034458704 cites W2046141067 @default.
• W2034458704 cites W2046959088 @default.
• W2034458704 cites W2048136153 @default.
• W2034458704 cites W2048354514 @default.
• W2034458704 cites W2051614350 @default.
• W2034458704 cites W2058002657 @default.
• W2034458704 cites W2059426381 @default.
• W2034458704 cites W2060460124 @default.
• W2034458704 cites W2066398399 @default.
• W2034458704 cites W2069271102 @default.
• W2034458704 cites W2069327346 @default.
• W2034458704 cites W2079699385 @default.
• W2034458704 cites W2079874135 @default.
• W2034458704 cites W2085646712 @default.
• W2034458704 cites W2088794717 @default.
• W2034458704 cites W2096327359 @default.
• W2034458704 cites W2102238081 @default.
• W2034458704 cites W2129166365 @default.
• W2034458704 cites W2131548964 @default.
• W2034458704 cites W2142526970 @default.
• W2034458704 cites W2151400756 @default.
• W2034458704 cites W2152527752 @default.
• W2034458704 cites W2152726242 @default.
• W2034458704 cites W2158340752 @default.
• W2034458704 cites W2158507234 @default.
• W2034458704 cites W2164114077 @default.
• W2034458704 cites W2165624352 @default.
• W2034458704 cites W2166390550 @default.
• W2034458704 cites W2210160338 @default.
• W2034458704 cites W2285642975 @default.
• W2034458704 cites W2322328224 @default.
• W2034458704 cites W2418810272 @default.
• W2034458704 cites W2419043963 @default.
• W2034458704 cites W298487901 @default.
• W2034458704 doi "https://doi.org/10.2147/vhrm.s36641" @default.
• W2034458704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4018418" @default.
• W2034458704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24851052" @default.
• W2034458704 hasPublicationYear "2014" @default.
• W2034458704 type Work @default.
• W2034458704 sameAs 2034458704 @default.
• W2034458704 citedByCount "27" @default.
• W2034458704 countsByYear W20344587042014 @default.
• W2034458704 countsByYear W20344587042015 @default.
• W2034458704 countsByYear W20344587042016 @default.
• W2034458704 countsByYear W20344587042017 @default.
• W2034458704 countsByYear W20344587042018 @default.
• W2034458704 countsByYear W20344587042019 @default.
• W2034458704 countsByYear W20344587042020 @default.
• W2034458704 countsByYear W20344587042021 @default.
• W2034458704 countsByYear W20344587042022 @default.
• W2034458704 crossrefType "journal-article" @default.
• W2034458704 hasAuthorship W2034458704A5019289431 @default.
• W2034458704 hasAuthorship W2034458704A5085702429 @default.
• W2034458704 hasAuthorship W2034458704A5085875890 @default.

• next